163 related articles for article (PubMed ID: 35977459)
1. Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectives.
Austin EJ; Corcorran MA; Briggs ES; Frost MC; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Jarlais DCD; Williams EC; Glick SN
Int J Drug Policy; 2022 Nov; 109():103825. PubMed ID: 35977459
[TBL] [Abstract][Full Text] [Related]
2. Program Adaptations to Provide Harm Reduction Services During the COVID-19 Pandemic: A Qualitative Study of Syringe Services Programs in the U.S.
Frost MC; Sweek EW; Austin EJ; Corcorran MA; Juarez AM; Frank ND; Prohaska SM; LaKosky PA; Asher AK; Broz D; Jarlais DCD; Williams EC; Glick SN
AIDS Behav; 2022 Jan; 26(1):57-68. PubMed ID: 34110506
[TBL] [Abstract][Full Text] [Related]
3. The effects of COVID-19 on New York State's Drug User Health Hubs and syringe service programs: a qualitative study.
Ude M; Behrends CN; Kelly S; Schackman BR; Clear A; Goldberg R; Gelberg K; Kapadia SN
Harm Reduct J; 2023 Feb; 20(1):12. PubMed ID: 36732773
[TBL] [Abstract][Full Text] [Related]
4. Responding to a surge in overdose deaths: perspectives from US syringe services programs.
Frost MC; Austin EJ; Corcorran MA; Briggs ES; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC; Williams EC; Glick SN
Harm Reduct J; 2022 Jul; 19(1):79. PubMed ID: 35854351
[TBL] [Abstract][Full Text] [Related]
5. Exploring the impact of the COVID-19 pandemic on syringe services programs in rural Kentucky.
Glick JL; Grieb SM; Harris SJ; Weir BW; Smith KC; Puryear T; Hamilton White R; Allen ST
Harm Reduct J; 2022 May; 19(1):47. PubMed ID: 35590373
[TBL] [Abstract][Full Text] [Related]
6. Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020.
Behrends CN; Lu X; Corry GJ; LaKosky P; Prohaska SM; Glick SN; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC
Drug Alcohol Depend; 2022 Mar; 232():109323. PubMed ID: 35124386
[TBL] [Abstract][Full Text] [Related]
7. Syringe Service Program Perspectives on Barriers, Readiness, and Programmatic Needs to Support Rollout of the COVID-19 Vaccine.
Corcorran MA; Austin EJ; Behrends CN; Briggs ES; Frost MC; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC; Williams EC; Glick SN
J Addict Med; 2023 Jan-Feb 01; 17(1):e36-e41. PubMed ID: 35916422
[TBL] [Abstract][Full Text] [Related]
8. The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state.
Thakarar K; Kohut M; Hutchinson R; Bell R; Loeb HE; Burris D; Fairfield KM
Harm Reduct J; 2022 Jul; 19(1):80. PubMed ID: 35869523
[TBL] [Abstract][Full Text] [Related]
9. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs.
Allen ST; Grieb SM; O'Rourke A; Yoder R; Planchet E; White RH; Sherman SG
Harm Reduct J; 2019 May; 16(1):33. PubMed ID: 31109339
[TBL] [Abstract][Full Text] [Related]
10. Police officer attitudes towards syringe services programming.
Sightes E; Ray B; Paquet SR; Bailey K; Huynh P; Weintraut M
Drug Alcohol Depend; 2019 Dec; 205():107617. PubMed ID: 31707271
[TBL] [Abstract][Full Text] [Related]
11. HCV serostatus and injection sharing practices among those who obtain syringes from pharmacies and directly and indirectly from syringe services programs in rural New England.
Romo E; Rudolph AE; Stopka TJ; Wang B; Jesdale BM; Friedmann PD
Addict Sci Clin Pract; 2023 Jan; 18(1):2. PubMed ID: 36597153
[TBL] [Abstract][Full Text] [Related]
12. "We were building the plane as we were flying it, and we somehow made it to the other end": syringe service program staff experiences and well-being during the COVID-19 pandemic.
Wang A; Jawa R; Mackin S; Whynott L; Buchholz C; Childs E; Bazzi AR
Harm Reduct J; 2022 Jul; 19(1):78. PubMed ID: 35841101
[TBL] [Abstract][Full Text] [Related]
13. Harm Reduction and Adaptations Among PWUD in Rural Oregon During COVID-19.
Seaman A; Leichtling G; Stack E; Gray M; Pope J; Larsen JE; Leahy JM; Gelberg L; Korthuis PT
AIDS Behav; 2021 May; 25(5):1331-1339. PubMed ID: 33471243
[TBL] [Abstract][Full Text] [Related]
14. State Laws Governing Syringe Services Programs and Participant Syringe Possession, 2014-2019.
Fernández-Viña MH; Prood NE; Herpolsheimer A; Waimberg J; Burris S
Public Health Rep; 2020; 135(1_suppl):128S-137S. PubMed ID: 32735195
[TBL] [Abstract][Full Text] [Related]
15. A qualitative analysis of rural syringe service program fidelity in Appalachian Kentucky: Staff and participant perspectives.
Batty EJ; Ibragimov U; Fadanelli M; Gross S; Cooper K; Klein E; Ballard AM; Young AM; Lockard AS; Oser CB; Cooper HLF
J Rural Health; 2023 Mar; 39(2):328-337. PubMed ID: 36117151
[TBL] [Abstract][Full Text] [Related]
16. Vaccination barriers and opportunities at syringe services programs in the United States, June-August 2021-A cross-sectional survey.
Montgomery MP; Zhong Y; Roberts E; Asher A; Bixler D; Doshani M; Christensen A; Eckert M; Weng MK; Carry M; Samuel CR; Teshale EH
Drug Alcohol Depend; 2022 Aug; 237():109540. PubMed ID: 35753280
[TBL] [Abstract][Full Text] [Related]
17. Acceptability of an mHealth App That Provides Harm Reduction Services Among People Who Inject Drugs: Survey Study.
Shelby T; Zhou X; Barber D; Altice F
J Med Internet Res; 2021 Jul; 23(7):e25428. PubMed ID: 34259640
[TBL] [Abstract][Full Text] [Related]
18. Implementation and first-year operating costs of an academic medical center-based syringe services program.
Bartholomew TS; Patel H; McCollister K; Feaster DJ; Tookes HE
Harm Reduct J; 2021 Nov; 18(1):116. PubMed ID: 34798887
[TBL] [Abstract][Full Text] [Related]
19. Access to HIV, Viral Hepatitis, and Substance Use Disorder Treatment/Overdose Prevention Services: A Qualitative Analysis of Syringe Service Programs (SSPs) Serving Rural PWID.
Carnes NA; Asher AK; Bohm MK; Bessler PA
Subst Use Misuse; 2021; 56(13):1933-1940. PubMed ID: 34353216
[TBL] [Abstract][Full Text] [Related]
20. Intersecting substance use treatment and harm reduction services: exploring the characteristics and service needs of a community-based sample of people who use drugs.
Krawczyk N; Allen ST; Schneider KE; Solomon K; Shah H; Morris M; Harris SJ; Sherman SG; Saloner B
Harm Reduct J; 2022 Aug; 19(1):95. PubMed ID: 36002850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]